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https://doi.org/10.1016/j.stemcr.2019.09.010SUMMARYX-linked juvenile retinoschisis (XLRS), linked to mutations in the RS1 gene, is a degenerative retinopathy with a retinal splitting
phenotype. We generated human induced pluripotent stem cells (hiPSCs) from patients to study XLRS in a 3D retinal organoid
in vitro differentiation system. This model recapitulates key features of XLRS including retinal splitting, defective retinoschisin produc-
tion, outer-segment defects, abnormal paxillin turnover, and impaired ER-Golgi transportation. RS1 mutation also affects the develop-
ment of photoreceptor sensory cilia and results in altered expression of other retinopathy-associated genes. CRISPR/Cas9 correction
of the disease-associated C625T mutation normalizes the splitting phenotype, outer-segment defects, paxillin dynamics, ciliary marker
expression, and transcriptome profiles. Likewise,mutating RS1 in control hiPSCs produces the disease-associated phenotypes. Finally, we
show that the C625Tmutation can be repaired precisely and efficiently using a base-editing approach. Taken together, our data establish
3D organoids as a valid disease model.INTRODUCTION
X-linked juvenile retinoschisis (XLRS), named after the
distinctive retinal splitting phenotype, is a relatively com-
mon early-onset degenerative disease of the central retina
with a worldwide prevalence at 1/5,000 to 1/20,000
(George et al., 1995; Molday et al., 2012). Clinical features
of XLRS include mild to severe and progressive loss of
central vision, radial streaks arising from foveal schisis,
splitting of inner retinal layers in the peripheral retina,
retinal detachment, and vitreous hemorrhage (Tantri
et al., 2004). RS1, the gene implicated in XLRS, encodes
a highly conserved secreted extracellular protein called
retinoschisin (RS1) (Sauer et al., 1997). RS1 is composed
of an N-terminal signal sequence that mediates protein
secretion via the ER pathway (Sauer et al., 1997; Wu and
Molday, 2003), followed by RS1 and discoidin domains
and a C-terminal segment specifically expressed in the906 Stem Cell Reports j Vol. 13 j 906–923 j November 12, 2019 j ª 2019 Th
This is an open access article under the CC BY-NC-ND license (http://creativretina and pineal gland (Takada et al., 2006). More than
190 mutations of RS1 gene have been associated with
XLRS, and most of them are located within the discoidin
domain, causing protein misfolding and retention in the
ER (Molday et al., 2012;Wang et al., 2002;Wu andMolday,
2003).
RS1 protein is mainly localized at the extracellular
surfaces of the inner segments of rod and cone photore-
ceptors in the retina as well as in bipolar cells and two
plexiform layers (Molday et al., 2001). Furthermore, an
Rs1 knockout mouse study revealed that Rs1 is essential
for maintaining cell-to-cell interactions of retinal cells
(Reid et al., 2003). Although mouse models can be a useful
tool for studying the disease mechanism of retinopathies,
mouse and human retinas are not equivalent. For
example, the rod-to-cone ratios differ significantly be-
tween mouse (a nocturnal species) and human foveas
(Mustafi et al., 2009; Peirson et al., 2018; Volland et al.,e Authors.
ecommons.org/licenses/by-nc-nd/4.0/).
2015). Besides, several mouse models of retinal disorders
have failed to recapitulate disease-relevant phenotypes
(Garanto et al., 2013; Liu et al., 1997). This leaves ques-
tions as to whether mouse in vivo models are a suitable
surrogate for studying the functions of normal and
mutant human RS1 in retinal development or XLRS. Simi-
larly, immortalized human photoreceptor cell models are
lacking, making it difficult to uncover the interactions be-
tween RS1 and other factors involved in photoreceptor
function and biogenesis.
Human induced pluripotent stem cells (hiPSCs) have
emerged as a promising alternative to animal-based disease
modeling systems. hiPSCs can be generated from patients,
expanded indefinitely, and differentiated into specific cells
and tissue types relevant for disease modeling (Chou et al.,
2017; Meyer et al., 2011; Parfitt et al., 2016; Singh et al.,
2013). Moreover, hiPSCs allow the discovery and func-
tional validation of genotype-phenotype relationships
in patient-specific genetic backgrounds. Several recent
studies have utilized hiPSCs to study human hereditary
retinopathies (Deng et al., 2018; Ohlemacher et al., 2016;
Parfitt et al., 2016). However, so far, hiPSC-derived retinal
cells have not been used to study themolecular and cellular
mechanisms that underlie the pathology of XLRS. In this
study, we enrolled XLRS patients with RS1 mutations for
generating patient-specific hiPSCs, and further established
3D retinal organoids from the patient-specific hiPSCs for
diseasemodeling of XLRS.We show that XLRS-patient-spe-
cific hiPSC-derived retinal organoids exhibit structural de-
fects similar to those found in patient retinas. Phenotypes
include a reduction in rod and cone cell frequencies, de-
fects in the connecting cilium, and accelerated paxillin
dynamics, as well as a progressive loss of expression of
IQCB1 and OPA1, two retinal genes associated with hered-
itary ocular diseases. Importantly, the observed pheno-
types were abrogated in retinal organoids generated from
gene-repaired hiPSCs, validating this system as a tool to
study XLRS. Furthermore, we generated multiple sets of
isogenic hiPSCs to confirm specificity of the genotype-
phenotype relationships. CRISPR repair was efficient
(50%), but also generated frequent indels. To avoid gener-
ating inadvertent indels, we evaluated Cas9-ABE7.10
mediated base editing as an alternative method to repair
the RS1 locus and found it to be equally efficient.RESULTS
Generation of the XLRS-Patient-Specific hiPSC-
Derived 3D Retinal Organoids as an In Vitro
Retinoschisis Disease Model
Two patients diagnosed with XLRS (Pt-1 and Pt-2) and two
control donors (Ctrl-1 and Ctrl-2) were enrolled in thisstudy. Two XLRS patients exhibited abnormal retinal
splitting and bilateral macular atrophy with cartwheel
appearance, as detected by dilated indirect ophthalmos-
copy (Figure 1A). Full-field electroretinography (ERG)
revealed markedly reduced amplitude in dark-adapted
0.01 ERG (rod response), light-adapted 3.0 ERG (cone
response), and light-adapted 3.0 flicker responses (Fig-
ure S1A). Pt-1 and Pt-2 were found to carry RS1 mutations
respectively at c.625C>T (p.R209C) and c.488G>A
(p.W163X) (Figure S1B). Peripheral blood mononuclear
cells from XLRS patients and control donors were reprog-
rammed into hiPSCs using the non-viral episomal plasmid
protocol (Okita et al., 2013) (Table S1). At least two inde-
pendent hiPSC clonal lines were generated from each
XLRS patient or control donor, and all control-donor-
and patient-derived hiPSC clones exhibited normal karyo-
types and expressed human PSC markers (Figures S2A–
S2C). Genotyping of the XLRS patient-derived hiPSC
clones confirmed the presence of the respective RS1
mutations at c.625C>T and c.488G>A (Figure 1B) (Peng
et al., 2018). We then applied a stepwise three-dimensional
(3D) retinal organoid formation protocol (Figure 1C) (Oh-
lemacher et al., 2015; Zhong et al., 2014) on the hiPSCs
of control donors (Ctrl-1 and Ctrl-2) and XLRS patients
(Pt-1 and Pt-2) to generate 3D retinal organoids. In the early
stage of retinal differentiation, control and patient-derived
organoids expressed markers of anterior neuroectoderm
commitment (LHX2, PAX6, and OTX2) at day 13 (Fig-
ure S3A). On day 20, the densely packed neural rosettes
were isolated and cultured in suspension, which resulted
in formation of 3D retinal cups (RCs) by day 30 (Figure 1D).
At this stage, RCs contained numerous VSX2- and Ki-67-
positive retinal progenitor cells (Figure S3B). We continued
the differentiation of control RCs (Ctrl-1 and Ctrl-2) and
patient RCs (Pt-1 and Pt-2) to day 150. The expression of
the photoreceptor-specific protein RCVRN (Recoverin)
increased continuously from day 90 to day 150 (Figure 1E).
In contrast, while RS1 expression increased over time in
control RCs, its overall expression was reduced in Pt-1
RCs and virtually absent in Pt-2 RCs (Figure 1E). Moreover,
we also observed an overt retinoschisis phenotype in RCs
derived fromboth patients fromday 100, but not in control
RCs, during differentiation (Figure 1F), which is reminis-
cent of the clinical characteristics of XLRS, i.e., the splitting
(schisis) of the retina between outer and inner nuclear
layers. In addition, immunofluorescent staining of RS1 pro-
tein in patient RCs confirms the location of RS1 proteins in
the outer layer of the developing retina and the signifi-
cantly decreased expression from day 120 in comparison
with control RCs (Figure 1G).
To further validate the incidence of retinoschisis and the
size of schisis area in RS1-mutant iPSC RCs, we compared
patient RCswith control RCs at 150 days.We firstmeasuredStem Cell Reports j Vol. 13 j 906–923 j November 12, 2019 907
Figure 1. 3D Retinal Organoids Modeling XLRS from Patient-Specific hiPSCs
(A and B) Color fundus photograph (left panel) and optical coherence tomography (OCT) images (right panel) of two X-linked juvenile
retinoschisis (XLRS) patients (Pt-1 and Pt-2). (B) DNA sequencing of RS1 mutation in hiPSCs (B). The position of a nucleotide change
625C>T (Pt-1) and 488G>A (Pt-2).
(C) Schematic diagram of differentiation procedure from iPSCs into 3D retinal organoids.
(D) Morphology of 3D retinal cups (RCs) at day 30 of differentiation in two controls (Ctrl-1 and Ctrl-2), Pt-1, and Pt-2 lines. Scale bar,
200 mm.
(E) Western blotting of RCVRN and RS1 expression at distinct differentiated time points of Ctrl-1, Ctrl-2, Pt-1, and Pt-2 RCs.
(F) Bright-field images of control RCs and patient RCs at days 90, 100, and 110 of differentiation. The white arrows indicate the splitting
(schisis) regions within patient RCs. Scale bar, 200 mm.
(G) Immunofluorescence staining of RS1 (red) and photoreceptor marker RCVRN (green) in the outer layer of RCs at days 90, 120, and 150.
Scale bar, 50 mm.
(H) Bright-field images from each of the two clones of control RCs and patient RCs at day 150 of differentiation. The red arrowheads
indicate the splitting (schisis) regions within patient RCs. Scale bar, 1,000 mm.
(I) Quantification of the ratio of RCs between schisis and non-schisis phenotype. For each sample, a total of over 80 RCs from two iPSC
clones were counted, and the data presents the mean value from three independent experiments. Chi-squared test was used for statistical
analysis with p < 0.0001.
(J) H&E-stained 150-day RCs. The lower panel shows the retinal nuclear layer in RCs and the areas (between the two dotted lines) that were
used for splitting layer quantification. The percentage of splitting layer was calculated by the ratio of the white (cell-free) area and the
total area between outer nuclear layer and inner nuclear layer of each RC. Scale bar, 200 mm.
(K) Quantification of splitting layer area in 150-day control RCs and patient RCs (n = 20 for each group from 3 independent experiments).
Error bars represent SEM. One-way ANOVA was used for statistical analysis (****p < 0.0001). See also Figures S1–S4.
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the penetration of the schisis phenotype in the RCs
harboring RS1 mutation. We evaluated about 200
RCs (about 25 per hiPSC-clone-derived RCs) from two
independent hiPSC clones for each of the two patients
and for each of the two healthy donor controls. All sets of
mutant RCs showed at least 80% of abnormal-looking
RCs with cyst/schisis-like features while fewer than 20%
of healthy-donor-derived RCs had that phenotype. All
pairwise comparisons of mutant and normal donor RC
datasets reached the level of statistical significance (Fig-
ures 1H–1I and S4A). As a measure of the magnitude of
the defect we calculated the size of the split area between
the outer nuclear layer (ONL) and inner nuclear layer
(INL) of 150-day control and patient RCs (Figure S3C).
The average size of the split area was increased in cross-sec-
tions of patient-derived mutant RCs compared with con-
trol RCs (Figures 1J, 1K, and S4B). These data indicated
that RS1 protein expression positively correlates with the
integrity of RC structure, especially the attachment be-
tween ONL and INL, and reflected the hiPSC-derived 3D
retinal organoids as a suitable in vitro retinoschisis disease
model.
Mutated RS1 Leads to Defects on RS1 Protein Secretion
and Neuroretinal Outer-Segment Development
RS1 is a secreted protein that forms a disulfide-linked
homo-octameric complex (Molday et al., 2012). To
examine whether RS1 mutation affects its homo-octa-
meric complex formation, we separated the lysates
from wild-type and C625T-mutant RS1-transfected
HEK293 cells on a non-reducing gel, and showed that
wild-type RS1 migrated to a size of about 180 kDa,
consistent with the expected size of RS1 octamers (Fig-
ure 2A). In contrast, C625T-mutant RS1, despite robust
expression of the monomer, failed to produce the mature
complex and failed to secrete into the culture mediumFigure 2. Schisis Phenotype and Defective Photoreceptor Format
(A) Western blotting of RS1 protein expression in transfected wild-type
gel conditions.
(B) Western blotting of Ctrl-1, Pt-1, Ctrl-2, and Pt-2 RCs at 120 days. T
reducing condition. Actin was used as internal control.
(C) Immunofluorescence staining of RS1 with ER (GRP94) and Golgi (
(D and E) Quantification of RS1 co-localization with GRP94 (D) and G
(F) Immunofluorescence staining of RS1 with GRP94 and Golgi97 in 1
fication image of the left panel marked with a dotted box. The arrow
Scale bar, 10 mm.
(G and H) Quantification of RS1 co-localization with GRP94 (G) and G
(I–M) Immunofluorescence staining of rhodopsin, COX VI (labeled inne
RCs and C625T-RCs. (I) The arrows indicate the normal rod cell morp
density of rhodopsin and G/R opsin in 150-day control and C625T-RCs (
of cell density of COX IV and PKCa in 150-day control and C625T-RCs
Error bars represent SEM. Unpaired Student’s t test (D and E) and one-
not significant).
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similarly failed to produce mature RS1 octamers, and
total RS1 protein expression was much reduced in Pt-1
RCs or virtually absent in Pt-2 RCs (Figure 2B). Prior to
secretion, RS1 needs to transit through and mature in
the ER and the Golgi apparatus (Wang et al., 2002; Wu
and Molday, 2003). To examine where the process fails
with mutant RS1, we co-immunostained the cells for
RS1 and the ER marker GRP94 or the Golgi marker
Golgi97 in RS1-overexpressing HEK293 cells and day-
150 RCs. In the HEK293 cells, wild-type RS1 clearly
co-localized with both GRP94 and Golgi97 while
C625T mutant RS1 only co-localized efficiently with
GRP94 and showed little overlap with Golgi97 (Figures
2C–2E). Similarly, in the 150-day patient-derived RCs,
RS1 co-localization with GRP94 was reduced but re-
mained readily detectable, while virtually no mutant
protein co-localized with the Golgi marker (Figures 2F–
2H). Our results confirm the RS1 secretion defect that
may result from incomplete processing and transport of
the protein.
We further investigated the developing photoreceptor
and bipolar layers, where RS1 is known to be expressed
(Molday et al., 2001), of the retinal structures of control
and patient hiPSC-derived RCs. RCs derived from both
patients contained significantly fewer photoreceptor
cells, as assessed by rhodopsin and G/R opsin immunoflu-
orescence microscopy (Figures 2I and 2J). Cone cell (G/R
opsin) numbers were more severely reduced than rod
cell (rhodopsin) numbers (Figure 2K). In contrast, the fre-
quency of inner-segment (COX IV) and bipolar (PKCa)
cells was not disturbed in patient-derived RCs (Figures
2I, 2L, and 2M), despite the continued severe reduction
in RS1 expression (Figures 2J–2L). These results demon-
strated a correlation between mutated RS1 and the
outer-layer defects, which leads to the defect of proteinion in RS1-Mutated 3D RCs
and C625T-mutated HEK293 cells under reducing and non-reducing
he arrow indicates RS1 that migrated as ~180-kDa complex in non-
Golgi97) 48 h after transfection of HEK293 cells. Scale bar, 10 mm.
olgi97 (E) (n = 20 images from 3 independent experiments).
50-day control and C625T RCs. The right panel is a higher-magni-
s indicate the prominent mutant RS1-positive signal in C625T-RCs.
olgi97 (H) (n = 20 images from 3 independent experiments).
r segment) (I), G/R opsin, RS1 (J), and PKCa (L) in 150-day control
hology in control RCs. Scale bar, 20 mm. (K) Quantification of cell
n = 20 images from 3 independent experiments). (M) Quantification
(n = 20 images from 3 independent experiments).
way ANOVA were used for statistical analysis (****p < 0.0001; N.S.,
(legend on next page)
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secretion process and photoreceptor development cells in
3D organoids.
Mutated RS1 Disturbs the Neuronal Adhesion
Capabilities and the Outer-Segment Maturation
E-Cadherin is a homotypic cell-cell adhesion mediator
expressed in the neural retina (Xu et al., 2002), and RS1’s
interaction with the Na/K-ATPase transmembrane signal-
osome complex on photoreceptor and bipolar cells (Mol-
day et al., 2007) provides a possible link via SRC and FAK
to Paxillin, a focal adhesion protein critical for cell-matrix
interactions (Liang et al., 2006; Plossl et al., 2017; Richard-
son et al., 1997; Zaidel-Bar et al., 2007). To reveal potential
adhesion defects, we therefore stained 150-day RCs for
E-cadherin and paxillin. While the expression levels and
distribution of these proteins were seemingly unaffected,
the retinal tissue nevertheless appeared much less well
organized in patient-derived RCs, withmany large intercel-
lular gaps (Figure 3A). When we measured the assembly
and disassembly times of paxillin in dissociated retina cells,
in cells from dissociated 150-day RCs (Figure 3B) we
observed accelerated dynamics (Figures 3B and 3C), result-
ing in a faster focal adhesion turnover in patient-derived
cells (Figure 3D; Videos S1 and S2). The faster cycling of
paxillin thus may contribute to the observed structural
defects and diminished phototransduction in XLRS.
The connecting cilium is a structure critical for photore-
ceptor cell maturation and intraflagellar transport between
the inner segment and the light-sensing outer segment
(Adams et al., 2007; De Robertis, 1956). The defect of
outer-segment development prompted us to investigate
the structure of connecting cilia in RS1 mutated RCs. We
stained for the cilia markers ARL13B and glutamylated
tubulin (GT335) in 150-day RCVRN-positive RCs. ARL13B
and GT335 signals were both significantly reduced in pa-Figure 3. Disorganized Cilia Formation and Loss of Adhesion in X
(A) Immunofluorescence staining of E-cadherin and paxillin in 150-d
(B) TIRFM images showing focal adhesion dynamics in transfected m
dynamics over time in C625T mutant photoreceptor cells. Scale bar, 4
(C and D) Quantification of focal adhesion dynamics by measuring as
lapse of mApple-paxillin expression (n = 14 control RCs and 10 C625T
(E and F) Immunofluorescence staining of ARL13B (E) and tubulin GT
panel is the left panel marked with a dotted box. Scale bar, 50 mm.
(G) Quantification of cilium density of immunofluorescence in 150-
independent experiments).
(H) Immunofluorescence staining of rhodopsin, G/R opsin, blue ops
positive G/R and blue-opsin signal within outer-segment layer. Scale
(I) Classified shape of rod cell by rhodopsin staining. Scale bar, 10 m
(J) Transmission electron micrographs of 210-day RCs. OS, outer segm
nuclear layer; cc, connecting cilium; bb, basal body; ct, centriole. Sc
Error bars represent SEM. Unpaired Student’s t test was used for statis
Videos S1 and S2.
912 Stem Cell Reports j Vol. 13 j 906–923 j November 12, 2019tient-derived RC as compared with control RCs (Figures
3E–3G), implying that RS1-mutant photoreceptor cells
contained defective connecting cilia and outer-segment
structures.
Long-term differentiation triggered outer-segment for-
mation after day 180, and by day 210 control RCs con-
tained numerous mature-looking rod and cone cells
and a distinctive outer-segment layer. However, in pa-
tient-derived RCs, rod cells (rhodopsin) continued to be
less abundant, and very few G/R opsin and virtually no
proper blue-opsin cone cells were present (Figure 3H),
in line with the reduced frequency and immature
appearance or abnormal shape of neuroretinal outer
segment and photoreceptor cells observed in patient-
derived RC at earlier time points. Moreover, by immuno-
fluorescent staining and imaging of 150-day optic vesi-
cles we found that patient-derived RC rod cells were
frequently deformed (Figure 3I). To examine the organi-
zation of photoreceptors in more detail, we used trans-
mission electron microscopy (TEM). Control RC photo-
receptors at 210 days showed properly formed features
including the ONL, outer limiting membrane, and in-
ner-segment and outer-segment layers (Figure 3J).
Higher-magnification images revealed the centriole,
basal body, and transition zone of the connecting cilium
between the inner and outer segment of control RCs (Fig-
ure 3J). In contrast, patient-derived RC (Pt-1, c.625C>T)
photoreceptors frequently lacked a distinct outer
segment and contained large vesicles as well as basal
bodies that were localized in the center rather than at
the apical surface of the inner segment (Figure 3J). In
conclusion, these data revealed the abnormal
morphology and immature appearance of the outer
segment, reduced numbers of rod and cone cells, and
faster focal adhesion turnover in patient-derived RCs.LRS Retinal Organoids
ay RCs. Scale bar, 50 mm.
Apple-paxillin photoreceptor cells. The arrows indicate the paxillin
0 mm.
sembly, mature state, disassembly (C), and total duration (D) time
-RCs from 3 independent experiments).
335 (F) in 150-day RCs. A higher-magnification image in the right
day RCs from higher-magnification images. (n = 4 images from 3
in, and RS1 in 210-day whole-mount RCs. The arrows indicate the
bar, 50 mm.
m.
ent; IS, inner segment; OLM, outer limiting membrane; ONL, outer
ale bar, 0.5 mm.
tical analysis (*p < 0.05; ***p < 0.001; ****p < 0.0001). See also
(legend on next page)
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Efficient CRISPR/Cas9-Mediated Gene Correction of
the C625T Mutation of RS1 Gene in Patient-Specific
hiPSCs
Precise gene editing is a powerful tool for studying
and corroborating genotype-phenotype relationships in
hiPSC disease modeling, including ophthalmic diseases
(Chan et al., 2017). Next, we tested whether the C625T
mutation could also be repaired using a recently developed
Cas9-directed base-editing approach (Gaudelli et al., 2017).
To correct the C625T mutations of RS1 gene in hiPSCs
of patient 1 (Pt-1-hiPSCs) using CRISPR/Cas9 gene edit-
ing (Table S2), we designed a guide RNA (gRNA) target
sequence and a homologous repair template for convert-
ing the mutant Cys codon to an Arg codon, thereby
restoring a wild-type RS1 amino acid sequence (HDRRepair)
(Figure 4A). The correction template included two synon-
ymous single-nucleotide changes, at the positions 621
and 627 of RS1 (Figure 4A), to prevent Cas9 from cutting
the template or repaired DNA and to facilitate PCR
screening. Moreover, we employed two strategies for the
correction of C625T mutation: (1) co-transfection of
pCas9_GFP with a plasmid that included both a 950-bp
RS1 repair template and the gRNA expression cassette
(pRS1HR-gRNA), and (2) co-transfection of pCas9_GFP, a
gRNA expression plasmid, and a 190-nt single-stranded
RS1 repair oligonucleotide (Figure 4B). Both approaches
resulted in very high repair efficiencies, with over 50%
(plasmid homology template) and 20% (oligo homology
template) of the transfected cells having undergone pre-Figure 4. Design of the CRISPR/Cas9-Mediated Gene Correction o
(A) Schematic showing the segment of the RS1 genome sequence of wi
arrowhead indicates the mutation site of RS1c.625C>T; gRNA target reg
(B) Diagram of the RS1c.625C>T gene-correction strategy. HR, homolog
(C) Sanger sequencing of RS1 gene. The yellow bar indicates the loca
(D) Bright-field images of RCs at days 90, 100, and 110 of retinal dif
200 mm.
(E and F) H&E staining of the 150-day control, C625T, R1-RCs, and R2-
percentage of the splitting layer. Scale bar, 100 mm. (F) Quantificatio
layer was calculated by the ratio of white (cell-free) area and the to
dependent experiments).
(G and H) Western blotting of RS1 protein expression in 150-day RCs u
the RS1 migrated as ~180-kDa complex in non-reducing condition.
expression in 150-day RCs under reducing condition (H). The expres
periments).
(I–K) Immunofluorescence staining of RS1 with GRP94 and Golgi97 in
magnification image of the left panel marked with a dotted box. The a
RCs. Scale bar, 10 mm. Quantification of RS1 protein co-localization
experiments).
(L–N) Immunofluorescence staining of rhodopsin, COX VI (L), G/R op
indicate normal rod cell morphology. Scale bar, 20 mm. (N) Quantificat
images from 3 independent experiments).
Error bars represent SEM. One-way ANOVA was used for statistical analy
significant). See also Figures S5 and S6.
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confirmed by subcloning and Sanger sequencing. We
selected two successfully corrected clones from strategy 1
(R1) and strategy 2 (R2) (Figure 4C). Neither clone showed
any off-target mutations at the top-5 most likely gRNA
off-target sites (Figure S5). However, many uncorrected
clones contained indels. We therefore also evaluated RS1
repair by base editing, which has several advantages over
conventional CRISPR/Cas9-induced double-strand break/
homology-directed repair, particularly that it does not
introduce potentially deleterious indels and that it works
much better in post-mitotic cells, including sensory cells
(Yeh et al., 2018). When we transfected RS1 mutant
hiPSCs with expression plasmids for GFP, the base editor
ABE7.10 (Gaudelli et al., 2017), and a synthetic gRNA, we
again achieved a very high repair efficiency (>50%). As
expected, despite this high on-target repair efficiency, we
did not observe any proximal indels in the base-editing
target region of the RS1 locus (Figure S6). Collectively, we
demonstrated efficient and precise on-target CRISPR/
Cas9-mediated gene correction of the C625T mutation of
the RS1 gene in patient-specific hiPSCs.
CRISPR/Cas9-Mediated Correction of RS1 Gene
Restores Pathological Phenotype, RS1 Protein
Secretion, and the Adhesion Abilities of Retinal Outer
Segment in XLRS-iPSC-Derived Retinal Organoids
Following the establishment of RS1 gene-repaired iPSCs,
we differentiated the two repaired hiPSC clones (R1 andf RS1 C625T Mutant hiPSCs
ld-type (WT), C625T, and C625T corrected (HDRrepair) region. The red
ion is highlighted.
ous repair region; U6, gRNA promoter.
tion of correction of RS1c.625C>T.
ferentiation in CRISPR/Cas9-repaired clones, R1 and R2. Scale bar,
RCs (E). The areas within the two dotted lines were quantified as the
n of splitting-layer area in 150-day RCs. The percentage of splitting
tal area between ONL and INL of each RC (n = 5 images from 3 in-
nder reducing or non-reducing conditions (G). The arrow indicates
Actin was used as internal control. Quantification of RS1 protein
sion level was normalized to actin (n = 3 from 3 independent ex-
150-day RCs of C625T, R1, and R2 (I). The right panel is a higher-
rrows indicate the prominent mutant RS1-positive signal in C625T-
with GRP94 (J) or Golgi97 (K) (n = 4 images from 3 independent
sin, and RS1 (M) in 150-day RCs of C625T, R1, and R2. The arrows
ion of cell density of rhodopsin and G/R opsin in 150-day RCs (n = 3
sis (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; N.S., not
(legend on next page)
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R2) into 3D retinal organoids. The repaired clones lacked
the disease-specific overt schisis phenotype seen inmutant
RCs during differentiation (Figure 4D) and day 150 (Figures
4E and 4F). To investigate whether corrected RS1 regained
its ability to form the expected octameric complex and
undergo normal intracellular processing in the RCs, we
first separated the cell lysate of RCs derived from control,
patient-1, and two corrected iPSC clones. RCs from both
repaired hiPSC clones were able to produce the 180-kDa
RS1 homo-octamer (Figures 4G and 4H). Co-staining of
RS1 with GRP94 or Golgi97 revealed enhanced co-localiza-
tion of RS1 with the ER and Golgi apparatus in 150-day
repaired RCs (R1 and R2) compared with unrepaired pa-
tient RCs (Figures 4I–4K). These data indicated that repair
of the mutated RS1 gene restored proper intracellular
transit, octamerization, and secretion of RS1.
Since patient-derived RCs gave rise to abnormal outer-
segment and photoreceptor cells (Figure 2), we next exam-
ined these features in repaired RCs. Staining of rhodopsin
and G/R opsin revealed an increase in the number of
photoreceptor cells and normal outer-segment structure
at day 150 in repaired RCs; conversely, the patient RCs
contained fewer photoreceptor cells and abnormal outer-
segment structures (Figures 4L–4N). Whole-mount stain-
ing of 210-day RCs also showed that repaired, but not un-
repaired patient RCs contained rhodopsin or G/R opsin-ex-
pressing photoreceptor cells in the region of outer
segments, as well as blue-opsin-positive cells of normal
shape (Figure S3D).
Next, we checked whether connecting cilia and paxillin
dynamics were also recovered in repaired RCs. Immuno-
staining of dissociated 150-day repaired RCs with connect-
ing cilia markers showed that the cilia signals were
increased in repaired RCs (Figures 5A–5C) and staining for
E-cadherin andpaxillin demonstrated a thicker, better orga-
nized, and more intact retinal tissue structure as well (Fig-
ure 5D). Furthermore, paxillin dynamics were stabilized in
dissociated retinal cells from control RCs and repaired RCsFigure 5. Regaining Cilia Formation and Cellular Adhesion in CRI
(A–D) Immunofluorescence staining of ARL13B (A) and tubulin GT335
is the left panel marked with a dotted box. Scale bar, 50 mm. (C) Quan
from higher-magnification images (n = 3 images from 3 independent
paxillin in 150-day RCs. Scale bar, 50 mm.
(E) TIRFM images showing focal adhesion dynamics in photorecepto
paxillin dynamics in C625T mutant photoreceptor cells. Scale bar, 40
(F–H) Quantification of focal adhesion dynamics by measuring assemb
of mApple-paxillin expression (n = 8 of C625T-RCs, 12 of R1-RCs, and
electron micrographs of 210-day RCs from Pt-1 (top) and R1 (bottom) i
RCs and the photos of R1 were taken from three sequential sections t
Scale bar, 0.5 mm.
(I) Schematic presentation of the effects of RS1 mutation on retinal
statistical analysis (*p < 0.05; **p < 0.01; ***p < 0.001). See also V
916 Stem Cell Reports j Vol. 13 j 906–923 j November 12, 2019compared with C625T-mutant RCs (Figures 5E–5G; Videos
S3 and S4). Furthermore, consistent with the recovery of
mature photoreceptor cells and ciliary markers as observed
by immunofluorescence, TEManalysis revealed that proper
outer segments and sensory cilia formed in repaired RCs
(Figure 5H). Taken together, CRISPR-mediated RS1 gene
correction resulted in a normalization of the schisis pheno-
type, increased cilia marker expression, and stabilized pax-
illin dynamics and recovery of outer-segment structure for-
mation, as well as RS1 secretion (Figure 5I).
CRISPR/Cas9-Directed RS1 Point Mutation in Control
iPSCs Leads to Schisis Phenotype in Differentiated
Retinal Organoids
To further ensure that the retinoschisis phenotypes are
indeed caused by RS1 mutation, we used CRISPR/Cas9
gene editing to generate two RS1 mutated clones (RS1-
M1 and RS1-M2) from a healthy donor hiPSC line (Table
S2). We designed a single gRNA target sequence and a ho-
mologous template for converting the wild-type Arg
codon in Ctrl-1 hiPSCs to a Cys codon, thereby creating
a mutated RS1 amino acid sequence (RS1-M1 and RS1-
M2; Figures 6A and 6B). At 120 days of organoid differen-
tiation, the CRISPR-induced RS1 C625T mutation led to
large schisis area in RCs in comparison with the control
RCs (Figures 6C and 6D). Consistent with previous data,
RCs generated from RS1-M1- and RS1-M2-hiPSCs ex-
hibited decreased co-localization of RS1 with GRP94 and
Golgi97 (Figures 6E–6G) accompanied by reduced RS1
expression (Figure 6E). Moreover, immunostaining of
the photoreceptor markers showed a reduced number of
rhodopsin- and G/R opsin-expressing cells (Figures 6H–
6J). As expected, the ability of the CRISPR-directed
C625T-mutant RS1 protein to form homo-octamer com-
plexes was lost (Figure 6K). In summary, by generating
isogenic sets of RS1 mutant from wild-type control
hiPSCs, we were able to confirm strict genotype-pheno-
type relationships of XLRS. These data also suggest thatSPR/Cas9-Corrected Retinal Organoids
(B) in 150-day RCs. A higher-magnification image in the right panel
tification of cilium density of immunofluorescence in 150-day RCs
experiments). (D) Immunofluorescence staining of E-cadherin and
r cells transfected with mApple-paxillin. The arrows indicate the
mm.
ly, mature state, disassembly (F), and total duration time lapse (G)
12 of R2-RCs from 3 independent experiments). (H) Transmission
PSCs. The photos of Pt-1 were taken from three different positions of
o show the structure of centriole and photoreceptor-like structure.
phenotype. Error bars represent SEM. One-way ANOVA was used for
ideos S3 and S4.
(legend on next page)
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CRISPR/Cas9-directed gene editing is a potential platform
to generate an in vitro study model for diseases caused by
defined gene mutation such as XLRS.RNA Sequencing Reveals Reduced Expression of Two
Other Ophthalmic Disease Genes, IQBT1 andOPA1, in
RS1-Mutant Retinal Organoids
To gain further insights into themolecular defects in XLRS,
we performed deep sequencing of the total RNA extracted
from control RCs, patient RCs (Pt-1, c.625C>T), R1-RCs,
and R2-RCs at various time points (days 0–150). As shown
by Pearson correlation analysis, the transcriptomes of
control RCs and C625T-RCs considerably diverged along
the time course of differentiation, with the difference
becoming more pronounced at the later time points (Fig-
ure 7A). In contrast, analysis of repaired RCs revealed
transcriptomes that were highly similar to those of con-
trol RCs and significantly different from those of patient
RCs (Figure 7B). Because RS1 is only expressed in the later
stage of differentiation, we focused on days 90, 120, and
150 post induction and analyzed the genes whose expres-
sion was reduced at least 2-fold in patient RCs (Figure 7C).
Among all of these genes, 326 genes were overexpressed
in normal RCs at all of these stages (Table S4), emphasizing
their importance (Figure 7D, left). According to gene set
enrichment analysis (GSEA) annotation, 9 out of these
326 genes were implicated in eye development (Figure 7D,
right). Notably, among these nine genes the expression of
RS1, IQCB1, and OPA1 was rescued in CRISPR-repaired
RCs (Figure 7E). The relative loss of expression became
even more prominent in later stages of retinal differentia-
tion (Figure 7F). Notably, IQCB1 mutations are associated
with Leber congenital amaurosis, a ciliopathy that affects
the retina, and IQCB1 mutant retinas fail to produceFigure 6. Characterization of RCs Derived from CRISPR/Cas9-Inse
(A) Schematic showing the segment of the RS1 genome sequence of wi
red arrowhead indicates the mutation site of RS1c.625C>T; gRNA target
(B) Sanger sequencing of RS1 gene. The yellow bar indicates the loca
(C) Bright-field images of 150-day RCs differentiated from Ctrl-1, M1
(D) H&E staining of the 150-day control, M1-RCs, and M2-RCs. The are
splitting layer. The percentage of splitting layer was calculated by the
nuclear layer and inner nuclear layer of each RC. Scale bar, 100 mm. The
right panel (n = 5 images from 3 independent experiments).
(E) Immunofluorescence staining of RS1 with GRP94 and Golgi97 in
magnification image of the left panel marked with a dotted box. Scal
(F and G) Quantification of RS1 protein co-localization with GRP94 (F
(H and I) Immunofluorescence staining of rhodopsin, COX VI (H), G/R
arrows indicate normal rod cell morphology. Scale bar, 20 mm.
(J) Quantification of cell density of rhodopsin and G/R opsin in 150-
(K) Western blotting of RS1 protein expression in 120-day Ctrl-1 RCs, M
arrow indicates the RS1 migrated as ~180-kDa complex in non-reduci
Error bars represented SEM. One-way ANOVA was used for statistical an
not significant).
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et al., 2016), reminiscent of what we observed in this
study with RS1 mutant RCs. OPA1, on the other hand, is
a mitochondrial fusion protein that has been linked to
autosomal dominant optic atrophy, a degenerative condi-
tion that affects retinal ganglion cells (Ronquillo et al.,
2016; Wang et al., 2006). Thus, the results of our tran-
scriptomics analysis reflect the progressive nature of the
disease phenotypes observed in RS1-mutant RCs, mirror
the observed ciliary phenotype, and reveal potential links
of XLRS to other hereditary retinopathies.DISCUSSION
XLRS is an early-onset congenital macular degeneration
associated with the RS1 gene (Molday et al., 2012). RS1
protein is necessary for a complex interplay between
distinct cell types and layers in laminated retinal tissue,
as it is present in the inner segments of rod and cone
photoreceptors, the outer plexiform layer (OPL), and the
INL (Molday et al., 2001). Conventional methods of
differentiating human embryonic stem cells or hiPSCs
into retinal cell lineages use a two-dimensional culture
system, and the resultant retinal cells lack tissue architec-
tural features typical for in vivo retina. However, genera-
tion of properly laminated retinal tissues (Figure 1C)
(Zhong et al., 2014) is uniquely suitable for addressing
such complex interactions and more similar to the devel-
opment of the human retina in vivo (Marangoni et al.,
2016). In our study, we used retinal organoids derived
from XLRS-hiPSCs, thus creating a human in vitro model
of XLRS. RS1mutant RCs mirror the retinal schisis pheno-
type seen in patients, exhibit RS1 protein production/
maturation defects, and produce fewer and mostlyrted C625T Mutation
ld-type (WT), C625T, and inserted mutation (HDRmutant) region. The
region is highlighted.
tion of correction/insertion of RS1c.625C>T.
, and M2 iPSC clones. Scale bar, 200 mm.
as within the two dotted lines were quantified as the percentage of
ratio of the white (cell-free) area and the total area between outer
quantification of splitting-layer area in 150-day RCs is shown in the
150-day RCs of Ctrl-1, M1, and M2. The right panel is a higher-
e bar, 10 mm.
) or Golgi97 (G) (n = 4 images from 3 independent experiments).
opsin, and RS1 (I) in 150-day Ctrl-1 RCs, M1-RCs, and M2-RCs. The
day RCs (n = 3 images from 3 independent experiments).
1-RCs, and M2-RCs under reducing or non-reducing conditions. The
ng condition. Actin was used as internal control.
alysis (*p < 0.05; **p < 0.01; ***p < 0.001; ****p < 0.0001; N.S.,
(legend on next page)
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abnormal photoreceptors with fewer connecting cilia.
Furthermore, dissociated RS1-mutant RC cells showed
altered paxillin dynamics (Table S3).
By modeling human retinal development in vitro, we
showed that RS1 is critical for the structural integrity of
the retinal layers in 3D organoids (Figures 2A–2C). In the
Rs1-knockout mice, mutant retinas were characterized by
delayed rod cell maturation and a higher threshold for
light-driven transducing translocation (Ziccardi et al.,
2012, 2014). However, this study shed little light on the
effects on cone cells (the cells most critical for resolving
colors and fine details), since cone cells are much less
frequent near the center of murine versus human foveas
(Volland et al., 2015), the area most critical for high visual
acuity. Our results highlight the utility of the hiPSC-RC
system for a more precise modeling of human retinopa-
thies, and revealed that pathological RS1 mutations result
in defective rod and cone cells.
Notably, we generated multiple sets of isogenic hiPSCs
to confirm specificity of the genotype-phenotype relation-
ships. Precise gene repair of the RS1 locus generated
isogenic clones in which all of the molecular and structural
deficiencies observed in patient-derived RCs were reversed
(Figures 4 and 5A–5C) and normal paxillin dynamics
were restored (Figures 5E–5G). We also generated RS1
C625Tmutation clones from control-donor-derived clones
through CRISPR/Cas9 gene editing; this panel of isogenic
control and CRISPR/Cas9-directed RS1 mutation clones
possess an identical genetic background except for RS1,
and thus served as an ideal model to study the pathogenic
effect of RS1 mutation during retinal development (Fig-
ure 6). These isogenic CRISPR/Cas9-repaired and CRISPR/
Cas9-directed RS1 mutant RCs are particularly valuable in
revealing the phenotype differences that are specific to
the RS1 mutation.
In addition to the previous view that RS1 plays a role in
cellular adhesion, mediating cell communication, and
providing structural support for the retinal layers (Pier-
marocchi et al., 2017; Wu et al., 2005), our transcriptome
analysis revealed significant changes in gene expression
between patient-derived and control RCs that become
more pronounced at the later stages of development.Figure 7. RNA Sequencing Reveals the RS1-Associated Changes o
(A) Pearson correlation analysis of gene-expression profiles in Ctrl-1
(B) Pearson correlation matrix showing similarity between gene-expr
(C) The pipeline of selecting differentially expressed genes at three p
(D) Left: Venn diagram demonstrating the numbers of common and
differentiation. Right: Venn diagram demonstrating the number of com
of differentiation and 215 genes of GSEA annotation ‘‘Eye developme
(E) Gene-expression matrix of the nine genes identified in (D).
(F) Time-course expression levels of the nine genes differentially exp
(G) Schematic of disease modeling from human 3D retinal organoid o
920 Stem Cell Reports j Vol. 13 j 906–923 j November 12, 2019This implies that RS1 is essential for normal retinal devel-
opment at the systemic level, possibly secondary to the
structural and cell-communication defects. Importantly,
the transcriptomes of CRISPR/Cas9-repaired hiPSCs
were more similar to those of controls. In an attempt to
identify important genes whose expression is abrogated
by RS1 mutation and rescued by CRISPR/Cas9 repair, we
identified IQCB1 and OPA1, encoding Nephrocystin-5
and mitochondrial dynamin like guanosine triphospha-
tase, respectively. The IQCB1 gene product is localized to
the transition zone of connecting cilia. Consistent with
the ciliary and outer-segment defects that we observed
in RS1-mutated RCs, IQCB1 is critical for the formation
of outer segments and has been linked to another retinop-
athy called Leber congenital amaurosis, a hereditary cili-
opathy (Ronquillo et al., 2016).OPA1, expressed primarily
in the inner segment and OPLs (Kam and Jeffery, 2015), is
a nuclear mitochondrial fusion gene associated with optic
atrophy type 1 (Wang et al., 2006). The loss of OPA1
expression thus may be related the impaired communica-
tion between sensory cells and other neuronal cells in the
retina and the atrophy of the optic nerve that is seen in
many XLRS patients (Genead et al., 2009). To summarize,
our RNA-sequencing data provide new molecular links
of XLRS to other retinopathies with overlapping clinical
phenotypes. Furthermore, the numerous and progressive
gene-expression changes point to additional direct or in-
direct (secondary to structural, adhesive, and ciliary de-
fects) roles of RS1 in multiple retinal processes and cell
types.
Collectively, we showed that the XLRS patient-specific
hiPSC-derived 3D retinal organoids can serve as a powerful
model system for investigating the pathophysiological
mechanism of this retinopathy. Our data revealed for the
first time the causative role of RS1 mutations in a human
in vitro system that allows detailed investigations of prena-
tal retinal development and of the molecular and cellular
mechanisms that underlie XLRS. Our study identifies po-
tential new targets for therapeutic intervention, such as
Paxillin and FIS1 (an antagonist of OPA1 [Lee et al.,
2007]) and suggests that development of the pathological
phenotypes may be preventable if efficient in vivo repairf Gene-Expression Landscape
RCs and Pt-1 RCs at different time points of differentiation.
ession profiles of 150-day Ctrl-1-, Pt-1-, R1-, and R2-RCs.
ost-induction time points of retinal differentiation.
unique differentially expressed genes between different stages of
mon genes between 326 genes differentially expressed at all stages
nt.’’
ressed in control RCs and C625T-RCs are shown in the charts.
f XLRS.
(such as by base editing) at the earliest time can be
achieved. Our in vitro model system may prove useful to
identify and validate targets for intervention as well as to
develop and optimize therapeutic approaches, including
in vivo gene therapy.EXPERIMENTAL PROCEDURES
Retinal Organoid Differentiation from Human iPSC
Lines
The method of differentiation into retinal organoids followed pre-
vious methods with slight modifications (Ohlemacher et al., 2015;
Wahlin et al., 2017; Zhong et al., 2014). Details of the differentia-
tion procedure are presented in Supplemental Experimental
Procedures.
CRISPR/Homology-Directed Repair RS1 Gene-Editing
Agents
The pCas9-GFP plasmid was used as previously described (Bur-
night et al., 2017). The guide RNA sequence (targeting sequence
underlined) was GGC ACG TCT GCA TTG CCA TCG TTT TAG
AGC TAG AAA TAG CAA GTT AAA ATA AGG CTA GTC CGT TAT
CAA CTT GAA AAA GTG GCA CCG AGT CGG TGC. The 190-b
RS1 oligo repair-template sequence was GTC TTC TAT GGC AAC
TCG GAC CGC ACC TCC ACG GTT CAG AAC CTG CTG CGG
CCC CCC ATC ATC TCC CGC TTC ATC CGC CTC ATC CCG
CTG GGC TGG CAT GTC CGG ATT GCC ATC CGG ATG GAG
CTG CTG GAG TGC GTC AGC AAG TGT GCC TGA TGC CTG
CCT CAG CTC GGC GCC TGC CAG GGG GTG ACT G. The
950-bp RS1 genomic sequence plasmid insert for homology-
directed repair of the C625T mutation contained the repair oligo
sequence in its center. Conversely, to introduce the C625T
(Arg209Cys) mutation in normal male hiPSC, the HDR template
sequence included the C to T pointmutation at the RS1 nucleotide
position 625, as well as two silentmutations, C to Tat position 621
and C to T at position 627, to facilitate genotyping and reduce cut-
ting of the edited locus or template (Figure 4A).
Othermaterial andmethods are detailed in Supplemental Exper-
imental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/
10.1016/j.stemcr.2019.09.010.
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